Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
Sartore G, Chilelli NC, Burlina S, Di Stefano P, Piarulli F, Fedele D, Mosca A, Lapolla A.
Acta Diabetol. 2012 Dec;49 Suppl 1:S153-60. doi: 10.1007/s00592-012-0391-4. Epub 2012 Apr 1.
Related citations
Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.
Sartore G, Chilelli NC, Burlina S, Lapolla A.
Acta Diabetol. 2013 Feb 16. [Epub ahead of print]
Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update.
Piarulli F, Sartore G, Lapolla A.
Acta Diabetol. 2013 Apr;50(2):101-10. doi: 10.1007/s00592-012-0412-3. Epub 2012 Jul 5.
The effects of psyllium on lipoproteins in type II diabetic patients.
Sartore G, Reitano R, Barison A, Magnanini P, Cosma C, Burlina S, Manzato E, Fedele D, Lapolla A.
Eur J Clin Nutr. 2009 Oct;63(10):1269-71. doi: 10.1038/ejcn.2009.60. Epub 2009 Jul 22.
Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: relationship with glyco-oxidation, lipid-oxidation and antioxidant status.
Sartore G, Piarulli F, Ragazzi E, Burlina S, Chilelli NC, Sarais C, Marin R, Manzato E, Fedele D, Lapolla A.
Int J Cardiol. 2013 Feb 20;163(2):201-5. doi: 10.1016/j.ijcard.2011.06.026. Epub 2011 Jun 21.
Glucose variability in diabetic pregnancy.
Dalfrà MG, Sartore G, Di Cianni G, Mello G, Lencioni C, Ottanelli S, Sposato J, Valgimigli F, Scuffi C, Scalese M, Lapolla A.
Diabetes Technol Ther. 2011 Aug;13(8):853-9. doi: 10.1089/dia.2010.0145.
Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients.
Piarulli F, Sartore G, Ceriello A, Ragazzi E, Reitano R, Nollino L, Cosma C, Fedele D, Lapolla A.
Diabetologia. 2009 Jul;52(7):1419-25. doi: 10.1007/s00125-009-1367-y. Epub 2009 Apr 29.
Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
Lapolla A, Piarulli F, Sartore G, Rossetti C, Martano L, Carraro P, De Paoli M, Fedele D.
Thromb Haemost. 2003 Jan;89(1):91-6.
Pentosidine plasma levels and relation with metabolic control in diabetic patients.
Lapolla A, Reitano R, Baccarin L, Sartore G, Plebani M, Fedele D.
Horm Metab Res. 2005 Apr;37(4):252-6.
Desaturase activities and metabolic control in type 2 diabetes.
Sartore G, Lapolla A, Reitano R, Zambon S, Romanato G, Marin R, Cosma C, Manzato E, Fedele D.
Prostaglandins Leukot Essent Fatty Acids. 2008 Jul-Aug;79(1-2):55-8. doi: 10.1016/j.plefa.2008.07.001. Epub 2008 Sep 3.
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease.
Lapolla A, Piarulli F, Sartore G, Ceriello A, Ragazzi E, Reitano R, Baccarin L, Laverda B, Fedele D.
Diabetes Care. 2007 Mar;30(3):670-6.
Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes.
Piarulli F, Lapolla A, Sartore G, Rossetti C, Bax G, Noale M, Minicuci N, Fiore C, Marchioro L, Manzato E, Fedele D.
Diabetes Care. 2005 Mar;28(3):653-7.
Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.
Roselli della Rovere G, Lapolla A, Sartore G, Rossetti C, Zambon S, Minicuci N, Crepaldi G, Fedele D, Manzato E.
Nutr Metab Cardiovasc Dis. 2003 Feb;13(1):46-51.
Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients.
Piarulli F, Lapolla A, Ragazzi E, Susana A, Sechi A, Nollino L, Cosma C, Fedele D, Sartore G.
Atherosclerosis. 2013 Jan;226(1):252-7. doi: 10.1016/j.atherosclerosis.2012.10.050. Epub 2012 Nov 9.
Plasma fatty acids and lipoproteins in type 2 diabetic patients.
Lapolla A, Sartore G, Della Rovere GR, Romanato G, Zambon S, Marin R, Manzato E, Fedele D.
Diabetes Metab Res Rev. 2006 May-Jun;22(3):226-31.
Genetic variability of the fructosamine 3-kinase gene in diabetic patients.
Mosca L, Penco S, Patrosso MC, Marocchi A, Lapolla A, Sartore G, Chilelli NC, Paleari R, Mosca A.
Clin Chem Lab Med. 2011 May;49(5):803-8. doi: 10.1515/CCLM.2011.133. Epub 2011 Feb 3.
An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients.
Seraglia R, Sartore G, Marin R, Burlina S, Manzato E, Ragazzi E, Traldi P, Lapolla A.
J Mass Spectrom. 2013 Jan;48(1):105-10. doi: 10.1002/jms.3113.
Calf and forearm blood flow in hypercholesterolemic patients.
Cortella A, Zambon S, Sartore G, Piarulli F, Calabrò A, Manzato E, Crepaldi G.
Angiology. 2000 Apr;51(4):309-18.
Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
Lapolla A, Reitano R, Seraglia R, Sartore G, Ragazzi E, Traldi P.
Mol Nutr Food Res. 2005 Jul;49(7):685-90.
Bariatric surgery improves atherogenic LDL profile by triglyceride reduction.
Zambon S, Romanato G, Sartore G, Marin R, Busetto L, Zanoni S, Favretti F, Sergi G, Fioretto P, Manzato E.
Obes Surg. 2009 Feb;19(2):190-5. doi: 10.1007/s11695-008-9644-2. Epub 2008 Sep 9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on